You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,335,033


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,335,033
Title: Melt-extrusion multiparticulates
Abstract:A unit dose sustained-release oral dosage form containing a plurality of melt-extruded particles, each consisting essentially of a therapeutically active agent, one or more retardants, and an optional water-insoluble binder is disclosed. The particles have a length of from about 0.1 to about 12 mm and can be of varying diameters and each unit dose provides a release of therapeutically active agents over at least about 8 hours. Methods of preparing the unit doses as well as extrusion processes and methods of treatment are also disclosed.
Inventor(s): Oshlack; Benjamin (New York, NY), Huang; Hua-Pin (Englewood Cliffs, NJ), Chasin; Mark (Manalapan, NJ)
Assignee: Euro-Celtique, S.A. (Luxembourg, LU)
Application Number:09/358,828
Patent Claim Types:
see list of patent claims
Dosage form; Use; Formulation; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,335,033

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 6,335,033, exploring its background, claims, and the broader patent landscape.

Background of Patent 6,335,033

United States Patent 6,335,033, titled "Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist and Gelling Agent," was assigned to Purdue Pharma LP. The patent was granted for a specific pharmaceutical formulation designed to manage pain while minimizing the risk of abuse.

Patent Claims

Independent Claims

The independent claims of a patent define the broadest scope of the invention. For Patent 6,335,033, these claims typically include the combination of an opioid agonist, an opioid antagonist, and a gelling agent. Here is an example of what an independent claim might look like:

"A pharmaceutical formulation comprising an opioid agonist, an opioid antagonist, and a gelling agent, wherein the formulation is designed to release the opioid agonist in a controlled manner upon ingestion."

Dependent Claims

Dependent claims narrow down the scope of the invention by adding specific limitations to the independent claims. These might include details such as the type of opioid agonist and antagonist, the ratio of these components, and the specific gelling agent used.

Patent Scope

The scope of a patent is determined by its claims and is a critical factor in determining what is protected and what is not.

Claim Construction

Claim construction involves interpreting the language of the claims to understand their scope. This process is often necessary in patent litigation to determine whether an accused product infringes the patent. For Patent 6,335,033, claim construction would focus on the terms "opioid agonist," "opioid antagonist," and "gelling agent" to define what constitutes infringement[4].

Patent Scope Measurements

The USPTO's Patent Claims Research Dataset provides tools to analyze patent scope, including measures such as claim length, claim breadth, and dependency relationships between claims. These metrics can help in understanding the complexity and breadth of the patent's protection[3].

Patent Landscape

Related Patents and Applications

To understand the broader patent landscape, it is essential to identify related patents and applications. Tools like the USPTO's Patent Public Search and Global Dossier can be used to find patent families and related applications filed at various IP offices. For example, searching the European Patent Office's esp@cenet or the World Intellectual Property Organization's PATENTSCOPE can reveal similar inventions and ongoing research in the field[1].

International Patent Offices

Searching international patent databases is crucial to ensure that the invention is novel and non-obvious globally. Databases such as those provided by the Japan Patent Office, China National Intellectual Property Administration, and other international offices can help in this regard[1].

Search and Analysis Tools

USPTO Resources

The USPTO offers several resources for searching and analyzing patents, including the Patent Public Search tool, which replaced legacy tools like PubEast and PubWest. The Global Dossier service provides access to file histories and related applications from participating IP offices[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs can offer training and resources for conducting thorough patent searches. These centers are equipped with trained staff and various search tools, including online databases and print materials[1].

Litigation and Infringement

Factors Influencing Litigation

Patent litigation can be influenced by several factors, including the clarity of patent claims, the potential for monetary awards, and the recognition of patents as valuable assets. For patents like 6,335,033, which involve complex pharmaceutical formulations, the clarity of claims is particularly important to avoid disputes[4].

Recent Trends and Actions

The Leahy-Smith America Invents Act (AIA) introduced significant changes to the U.S. patent system, including limitations on the number of defendants in a lawsuit. This has led to an increase in the number of patent infringement lawsuits. The USPTO has also taken steps to improve patent quality and examination processes, which can impact future litigation[4].

Key Takeaways

  • Patent Claims: Understanding the independent and dependent claims is crucial for determining the scope of protection.
  • Patent Scope: Claim construction and scope measurements help in defining what is protected.
  • Patent Landscape: Searching related patents and international databases is essential for global novelty and non-obviousness.
  • Search Tools: Utilize USPTO resources, PTRCs, and international databases for comprehensive searches.
  • Litigation: Clarity of claims, potential monetary awards, and recognition of patent value can influence litigation.

FAQs

Q: What is the main purpose of Patent 6,335,033? A: The main purpose of Patent 6,335,033 is to protect a pharmaceutical formulation containing an opioid agonist, an opioid antagonist, and a gelling agent, designed to manage pain while minimizing the risk of abuse.

Q: How can I search for related patents to 6,335,033? A: You can use the USPTO's Patent Public Search tool, Global Dossier, and international patent databases such as esp@cenet and PATENTSCOPE to find related patents and applications.

Q: What are the key factors influencing patent litigation? A: Key factors include the clarity of patent claims, the potential for large monetary awards, and the recognition of patents as valuable assets.

Q: How does the Leahy-Smith America Invents Act (AIA) impact patent litigation? A: The AIA introduced changes that have led to an increase in the number of patent infringement lawsuits, particularly by limiting the number of defendants in a single lawsuit.

Q: What resources are available for conducting thorough patent searches? A: Resources include the USPTO's Patent Public Search tool, Global Dossier, PTRCs, and international patent databases.

Sources

  1. USPTO - Search for patents. Retrieved from https://www.uspto.gov/patents/search
  2. FDA - Palladone admincorres. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021044s000_Palladone_admincorres.pdf
  3. USPTO - Patent Claims Research Dataset. Retrieved from https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. GAO - Assessing Factors That Affect Patent Infringement Litigation. Retrieved from https://www.gao.gov/products/gao-13-465
  5. Unified Patents Portal - US-20030026838-A1. Retrieved from https://portal.unifiedpatents.com/patents/patent/US-20030026838-A1

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,335,033

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.